Clinical Trial Update: BAY58-2667 Dose Finding Trial Investigating Fixed Doses in Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF) [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding trial of BAY58-2667 in patients with acute heart failure has been terminated. The study investigated fixed dosing in acute decompensated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• BAY58-2667

Snippet

Sponsor: Bayer | Conditions: Acute Heart Failure | Phase 2 | Status: TERMINATED